Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 4 2Phase 3 2Phase 1 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Mycosis Fungoides 2Sezary Syndrome 1Lymphoma 1

Interventions

liposomal amphotericin B 2hypericin 2Phototherapy 2Peripheral Blood Stem Cell Transplantation 2Methoxsalen 2Levofloxacin 2Early Intervention, Educational 2Darbepoetin alfa 2Bexarotene 2zanolimumab 1ferrous sulfate 1ferric gluconate 1Vorinostat 1Valacyclovir 1Ultraviolet Therapy 1Sucrose 1Radiotherapy 1Psychiatric Rehabilitation 1Pharmacogenomic Testing 1Ondansetron 1Moxifloxacin 1Morphine 1Methotrexate 1Lenalidomide 1Ketamine 1Itraconazole 1Fluconazole 1Filgrastim 1Fentanyl 1Epoetin Alfa 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Mycosis Fungoides × Methoxsalen × Clear all
NCT01686594 2018-11-14

M_PUVA_2012

Medical University of Graz

Phase 3 Completed
28 enrolled
Lymphoid

Mycosis Fungoides

NCT00056056 2018-07-09

Ultraviolet Light Therapy Using Methoxsalen With or Without Bexarotene in Treating Patients With Mycosis Fungoides

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Terminated
93 enrolled
Lymphoid

Lymphoma, Mycosis Fungoides, Sezary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡